1544 related articles for article (PubMed ID: 29798856)
21. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance.
Jiang X; Shimaoka T; Kojo S; Harada M; Watarai H; Wakao H; Ohkohchi N; Yonehara S; Taniguchi M; Seino K
J Immunol; 2005 Aug; 175(4):2051-5. PubMed ID: 16081769
[TBL] [Abstract][Full Text] [Related]
22. Gut Microbiota Modulates Interactions Between Polychlorinated Biphenyls and Bile Acid Homeostasis.
Cheng SL; Li X; Lehmler HJ; Phillips B; Shen D; Cui JY
Toxicol Sci; 2018 Dec; 166(2):269-287. PubMed ID: 30496569
[TBL] [Abstract][Full Text] [Related]
23. Interactions between bile salts, gut microbiota, and hepatic innate immunity.
Schubert K; Olde Damink SWM; von Bergen M; Schaap FG
Immunol Rev; 2017 Sep; 279(1):23-35. PubMed ID: 28856736
[TBL] [Abstract][Full Text] [Related]
24. Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders.
Collado A; Marques P; Escudero P; Rius C; Domingo E; Martinez-Hervás S; Real JT; Ascaso JF; Piqueras L; Sanz MJ
Cardiovasc Res; 2018 Nov; 114(13):1764-1775. PubMed ID: 29800106
[TBL] [Abstract][Full Text] [Related]
25. Precise delivery of obeticholic acid
Ji G; Ma L; Yao H; Ma S; Si X; Wang Y; Bao X; Ma L; Chen F; Ma C; Huang L; Fang X; Song W
Acta Pharm Sin B; 2020 Nov; 10(11):2171-2182. PubMed ID: 33304784
[TBL] [Abstract][Full Text] [Related]
26. Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota.
Chen J; Wei Y; He J; Cui G; Zhu Y; Lu C; Ding Y; Xue R; Bai L; Uede T; Li L; Diao H
Sci Rep; 2014 Dec; 4():7259. PubMed ID: 25435303
[TBL] [Abstract][Full Text] [Related]
27. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids.
Geissmann F; Cameron TO; Sidobre S; Manlongat N; Kronenberg M; Briskin MJ; Dustin ML; Littman DR
PLoS Biol; 2005 Apr; 3(4):e113. PubMed ID: 15799695
[TBL] [Abstract][Full Text] [Related]
28. CXCR6 expressing T cells: Functions and role in the control of tumors.
Mabrouk N; Tran T; Sam I; Pourmir I; Gruel N; Granier C; Pineau J; Gey A; Kobold S; Fabre E; Tartour E
Front Immunol; 2022; 13():1022136. PubMed ID: 36311728
[TBL] [Abstract][Full Text] [Related]
29. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.
Gazdic M; Simovic Markovic B; Vucicevic L; Nikolic T; Djonov V; Arsenijevic N; Trajkovic V; Lukic ML; Volarevic V
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1173-e1185. PubMed ID: 28488390
[TBL] [Abstract][Full Text] [Related]
31. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of Oxo-Bile Acids and Characterization of Recombinant 12α-Hydroxysteroid Dehydrogenases from Bile Acid 7α-Dehydroxylating Human Gut Bacteria.
Doden H; Sallam LA; Devendran S; Ly L; Doden G; Daniel SL; Alves JMP; Ridlon JM
Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29549099
[TBL] [Abstract][Full Text] [Related]
33. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma.
Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F
Front Immunol; 2018; 9():2750. PubMed ID: 30542347
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.
Sethi V; Kurtom S; Tarique M; Lavania S; Malchiodi Z; Hellmund L; Zhang L; Sharma U; Giri B; Garg B; Ferrantella A; Vickers SM; Banerjee S; Dawra R; Roy S; Ramakrishnan S; Saluja A; Dudeja V
Gastroenterology; 2018 Jul; 155(1):33-37.e6. PubMed ID: 29630898
[TBL] [Abstract][Full Text] [Related]
35. PBDEs Altered Gut Microbiome and Bile Acid Homeostasis in Male C57BL/6 Mice.
Li CY; Dempsey JL; Wang D; Lee S; Weigel KM; Fei Q; Bhatt DK; Prasad B; Raftery D; Gu H; Cui JY
Drug Metab Dispos; 2018 Aug; 46(8):1226-1240. PubMed ID: 29769268
[TBL] [Abstract][Full Text] [Related]
36. Natural killer T cells within the liver: conductors of the hepatic immune orchestra.
Swain MG
Dig Dis; 2010; 28(1):7-13. PubMed ID: 20460885
[TBL] [Abstract][Full Text] [Related]
37. Manipulating Liver Bile Acid Signaling by Nanodelivery of Bile Acid Receptor Modulators for Liver Cancer Immunotherapy.
Ji G; Si X; Dong S; Xu Y; Li M; Yang B; Tang Z; Fang X; Huang L; Song W; Chen X
Nano Lett; 2021 Aug; 21(16):6781-6791. PubMed ID: 34382807
[TBL] [Abstract][Full Text] [Related]
38. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
39. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.
Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA
J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945
[TBL] [Abstract][Full Text] [Related]
40. Bile Acid Metabolism in Liver Pathobiology.
Chiang JYL; Ferrell JM
Gene Expr; 2018 May; 18(2):71-87. PubMed ID: 29325602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
